N-(3-Chloro-4-methoxyphenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide

Catalog No. :
ACTDED432
CAS No. :
1775415-48-9
Molecular Formula :
C22H24ClN3O3
Molecular Weight :
413.90

IUPAC Name:N-(3-chloro-4-methoxyphenyl)-5-methyl-12-oxo-5,5a,6,7,8,9,10,12-octahydroazepino[2,1-b]quinazoline-3-carboxamide

N-(3-Chloro-4-methoxyphenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-Chloro-4-methoxyphenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide
IUPAC NameN-(3-chloro-4-methoxyphenyl)-5-methyl-12-oxo-5,5a,6,7,8,9,10,12-octahydroazepino[2,1-b]quinazoline-3-carboxamide
Molecular FormulaC22H24ClN3O3
Molecular Weight413.90
SMILESO=C(C1=CC(N(C)C2N3CCCCC2)=C(C=C1)C3=O)NC4=CC=C(OC)C(Cl)=C4
InChI KeyBAMRFDSPXBJWMF-UHFFFAOYSA-N
SynonymN-(3-chloro-4-methoxyphenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide;Azepino[2,1-b]quinazoline-3-carboxamide, N-(3-chloro-4-methoxyphenyl)-5,5a,6,7,8,9,10,12-octahydro-5-methyl-12-oxo-
CAS No.1775415-48-9

Synthetic Route by SureRoute

1. ACTDED432 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTDED432 route product structure diagram
    ACTDED4321775415-48-9
Inquiry

2. ACTDED432 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTDED432 route product structure diagram
    ACTDED4321775415-48-9
Inquiry

Comments (0)